Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.54 |
| ▸ | ITGAV | P06756 | 17/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.54 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.52 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5755977 | 0.94 | ITGB3 (0.60) | ITGB3ITGAVITGA2BITGB5MALT1 | |
| SCHEMBL13344587 | 0.90 | ITGB3 (0.58) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL13369313 | 0.87 | ITGB3 (0.48) | ITGB3ITGAVITGA2BMALT1 | |
| SCHEMBL243035 | 0.83 | ITGB3 (0.61) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL13369222 | 0.83 | ITGB3 (0.52) | ITGB3ITGAVITGA2BMALT1 | |
| SCHEMBL13344598 | 0.83 | ITGB3 (0.57) | ITGB3ITGAVITGA2BMALT1 | |
| SCHEMBL3541169 | 0.83 | ITGB3 (0.55) | ITGB3ITGAVITGA2BMALT1 | |
| SCHEMBL29262108 | 0.82 | ITGB3 (0.57) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL13344627 | 0.82 | ITGB3 (0.57) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL3536943 | 0.81 | ITGB3 (0.53) | ITGB3ITGAVITGA2BMALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718673-B2 | Isonipecotamides for the treatment of integrin-mediated disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718673-B2 | Isonipecotamides for the treatment of integrin-mediated disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2010-05-18 | — | — | US | disclosed |